As there are no data to support a specific sequence of regional versus systemic therapy or to guide sequencing of systemic therapy options, it is important for physicians to be aware of the available treatment options and emerging data on novel therapies so they can provide individualized care for their patients.

It is important to keep clinicians up to date with NCCN Guidelines for Neuroendocrine and Adrenal Tumors recommendations and with emerging data from clinical studies as this may help optimize treatment selection and ultimately improve clinical outcomes.

It is important to keep clinicians up to date with NCCN Guidelines for Neuroendocrine and Adrenal Tumors recommendations and with emerging data from clinical studies as this may help optimize treatment selection and ultimately improve clinical outcomes.

It is important to inform clinicians about this new section of the NCCN Guidelines for Neuroendocrine and Adrenal Tumors, which include recommendations for the evaluation, management, and surveillance of well-differentiated G3 NETs. Keeping clinicians abreast of updated treatment options may help improve clinical decision-making to better address patients’ medical needs.

It is important to inform clinicians about this new section of the NCCN Guidelines for Neuroendocrine and Adrenal Tumors, which include recommendations for the evaluation, management, and surveillance of well-differentiated G3 NETs. Keeping clinicians abreast of updated treatment options may help improve clinical decision-making to better address patients’ medical needs.

While there is a brand new treatment option for neuroendocrine tumors, it requires a wide array of practical guidance to be given safely and effectively.  Practitioners need to be well versed in patient eligibility, patient preparation for treatment, dosing, administration, and management of side effects.

While there is a brand new treatment option for neuroendocrine tumors, it requires a wide array of practical guidance to be given safely and effectively.  Practitioners need to be well versed in patient eligibility, patient preparation for treatment, dosing, administration, and management of side effects.

Clinicians need to stay current on the knowledge of benefits and risks, including the potential for lifetime radiation toxicity, of the multiple acceptable treatment strategies and apply high-level clinical evidence and expert advice to individualize the treatment and maximize outcomes.